Related references
Note: Only part of the references are listed.Contra-directional Coupling of Nur77 and Nurr1 in Neurodegeneration: A Novel Mechanism for Memantine-Induced Anti-inflammation and Anti-mitochondrial Impairment
Xiaobo Wei et al.
MOLECULAR NEUROBIOLOGY (2016)
Nurr1 and Retinoid X Receptor Ligands Stimulate Ret Signaling in Dopamine Neurons and Can Alleviate α-Synuclein Disrupted Gene Expression
Nikolaos Volakakis et al.
JOURNAL OF NEUROSCIENCE (2015)
New Treatments for Levodopa-Induced Motor Complications
Olivier Rascol et al.
MOVEMENT DISORDERS (2015)
The ongoing pursuit of neuroprotective therapies in Parkinson disease
Dilan Athauda et al.
NATURE REVIEWS NEUROLOGY (2015)
Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial
Stephane Palfi et al.
LANCET (2014)
Therapy for Parkinson's Disease: What is in the Pipeline?
Fabrizio Stocchi
NEUROTHERAPEUTICS (2014)
Low Dose Bexarotene Treatment Rescues Dopamine Neurons and Restores Behavioral Function in Models of Parkinson's Disease
Krista McFarland et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Genetic Correction of a LRRK2 Mutation in Human iPSCs Links Parkinsonian Neurodegeneration to ERK-Dependent Changes in Gene Expression
Peter Reinhardt et al.
CELL STEM CELL (2013)
Derivation and Expansion Using Only Small Molecules of Human Neural Progenitors for Neurodegenerative Disease Modeling
Peter Reinhardt et al.
PLOS ONE (2013)
Transcription factor Nurr1 maintains fiber integrity and nuclear-encoded mitochondrial gene expression in dopamine neurons
Banafsheh Kadkhodaei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Pollination Decline in Context Response
[Anonymous]
SCIENCE (2013)
Modulation of RXR function through ligand design
Efren Perez et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS (2012)
Advances in drug design with RXR modulators
Belen Vaz et al.
EXPERT OPINION ON DRUG DISCOVERY (2012)
Age-related changes in dopamine signaling in Nurr1 deficient mice as a model of Parkinson's disease
Lifen Zhang et al.
NEUROBIOLOGY OF AGING (2012)
When does Parkinson's disease begin? From prodromal disease to motor signs
W. G. Meissner
REVUE NEUROLOGIQUE (2012)
ApoE-Directed Therapeutics Rapidly Clear β-Amyloid and Reverse Deficits in AD Mouse Models
Paige E. Cramer et al.
SCIENCE (2012)
Monoamine Oxidase B Inhibitors for the Treatment of Parkinson's Disease A Review of Symptomatic and Potential Disease-Modifying Effects
Anthony H. V. Schapira
CNS DRUGS (2011)
Priorities in Parkinson's disease research
Wassilios G. Meissner et al.
NATURE REVIEWS DRUG DISCOVERY (2011)
Fcγ receptors are required for NF-κB signaling, microglial activation and dopaminergic neurodegeneration in an AAV-synuclein mouse model of Parkinson's disease
Shuwen Cao et al.
MOLECULAR NEURODEGENERATION (2010)
The Parkinson Disease Protein Leucine-Rich Repeat Kinase 2 Transduces Death Signals via Fas-Associated Protein with Death Domain and Caspase-8 in a Cellular Model of Neurodegeneration
Cherry Cheng-Ying Ho et al.
JOURNAL OF NEUROSCIENCE (2009)
Nurr1 Is Required for Maintenance of Maturing and Adult Midbrain Dopamine Neurons
Banafsheh Kadkhodaei et al.
JOURNAL OF NEUROSCIENCE (2009)
Characterisation of a novel NR4A2 mutation in Parkinson's disease brain
P. M. A. Sleiman et al.
NEUROSCIENCE LETTERS (2009)
Dopamine Gene Therapy for Parkinson's Disease in a Nonhuman Primate Without Associated Dyskinesia
Bechir Jarraya et al.
SCIENCE TRANSLATIONAL MEDICINE (2009)
Regulation of GTP cyclohydrolase I expression by orphan receptor Nurr1 in cell culture and in vivo
Minchan Gil et al.
JOURNAL OF NEUROCHEMISTRY (2007)
Protocol for the MPTP mouse model of Parkinson's disease
Vernice Jackson-Lewis et al.
NATURE PROTOCOLS (2007)
Extra precision glide: Docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes
Richard A. Friesner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Pathological changes in dopaminergic nerve cells of the substantia nigra and olfactory bulb in mice transgenic for truncated human α-synuclein (1-120):: Implications for Lewy body disorders
GK Tofaris et al.
JOURNAL OF NEUROSCIENCE (2006)
Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells
Å Wallén-Mackenzie et al.
GENES & DEVELOPMENT (2003)
Orphan nuclear receptor Nurr1 directly transactivates the promoter activity of the tyrosine hydroxylase gene in a cell-specific manner
KS Kim et al.
JOURNAL OF NEUROCHEMISTRY (2003)
Mutations in NR4A2 associated with familial Parkinson disease
WD Le et al.
NATURE GENETICS (2003)
Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra
RL Klein et al.
HUMAN GENE THERAPY (2002)
α-synuclein up-regulation in substantia nigra dopaminergic neurons following administration of the Parkinsonian toxin MPTP
M Vila et al.
JOURNAL OF NEUROCHEMISTRY (2000)
Share Paper
